Independent Pharmacy Cooperative has completed its acquisition of USave Pharmacy Group, with the deal taking effect on September 1 of this year.
The two purchasing organisations have worked in close collaboration for nearly a decade, making the transaction a formalisation of an already deeply embedded operational relationship.
USave Pharmacy Group has spent more than 40 years connecting independent pharmacy owners through purchasing opportunities, peer collaboration, and dedicated representation for locally owned pharmacies.
IPC first announced a formal agreement with the Nebraska-based pharmacy group in 2017, establishing a relationship focused on connecting USave pharmacies with IPC resources and purchasing opportunities.
“USave was built around pharmacy owners supporting pharmacy owners,” said Bill Hamik of USave Pharmacy Group, adding that stores value the relationships, responsiveness, and shared identity that come with being part of the group.
Hamik said that IPC understands that history and recognises that USave’s identity is something to preserve, not replace, allowing pharmacies to retain what they value while gaining access to additional resources.
Marc Essensa, President and CEO of IPC, said: “IPC’s purpose has always been to help independent pharmacies remain strong, locally owned and positioned for the future.”
Essensa described the acquisition as being about preserving a respected organisation, building on the trust it has earned, and bringing additional strength and resources to its pharmacies.
Kate Helf, IPC Vice President of Pharmacy Innovation, will serve as liaison ensuring continuity throughout the transition, having worked closely with USave Pharmacy Group for the past ten years.
The entire IPC team, spanning Member Service, Distribution, Member Performance, and Government Relations, will continue supporting USave pharmacies as they have since 2017.
The transaction follows a familiar playbook of pooling purchasing scale while allowing the acquired group to retain its own identity and community standing within the independent pharmacy sector.
For independent pharmacies, scale increasingly determines negotiating leverage with wholesalers and payers, making cooperative consolidation a practical countermeasure to mounting commercial pressure.
PBM concentration exceeding 80% of prescription volume has enabled below-acquisition-cost reimbursement terms that place significant financial strain on independent operators across the country.
Independent pharmacy closures exceed one per day despite independents comprising approximately 36% of all US retail pharmacy locations, underlining the urgency driving cooperative consolidation strategies.
IPC positions itself as a member-owned cooperative offering purchasing access, operational support, and advocacy to independent pharmacies nationally, with USave extending that footprint into a well-established regional base.
Neither company disclosed financial terms of the transaction, though the strategic rationale reflects broader pressures reshaping the independent pharmacy landscape across the United States.